PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Nat Immunol. Author manuscript; available in PMC 2010 August 30.
Published in final edited form as:
PMCID: PMC2929952
NIHMSID: NIHMS225556

The making of NKT cells

Abstract

Natural killer T cells acquire their unique phenotype and characteristics during development in the thymus. Evidence suggests that the transcription factor PLZF has a unique function in the development of these cells and their acquisition of ‘innate-like’ characteristics.

Multipotent progenitors from the bone marrow colonize the thymus and differentiate into various T-cell lineages in response to environmental and TCR derived signals that induce specific cell-intrinsic transcriptional programs. The molecular mechanisms driving these lineage-fate decisions have been the focus of intense research recently and have resulted in the identification of several pivotal transcription factors. For example, regulation of the γδ versus αβ T cell differentiation is mediated by the transcription factor Sox131, while Th-Pok acts as a master regulator of the CD4 versus the CD8 commitment step2. Similarly, Foxp3 is indispensable for the differentiation of regulatory T cells3. In this issue of Nature Immunology, the laboratory of Sant’Angelo reports an essential role for the promyelocytic leukemia zinc finger transcription factor, PLZF, in natural killer T (NKT) cell development4. Although a few iNKT cells can be found in mice deficient for PLZF, they do not appear to acquire the activated and “innate-like” phenotype that is characteristic of NKT cells, suggesting an essential role for PLZF in iNKT cell biology.

Natural Killer T (NKT) cells represent a distinct subset of T lymphocytes that has evolved to recognize glycolipid antigens presented by the non-classical MHC class I-like molecule, CD1d. Upon recognition of glycolipids, NKT cells respond by secreting large quantities of cytokines and chemokines within hours of their initial stimulation, reminiscent of innate rather than adaptive functions. These cells have been implicated in the regulation of immune responses associated with a broad range of diseases, including autoimmunity, infectious diseases and cancer (review ref?).

Type I NKT cells, also named iNKT cells, are the most prevalent NKT cells in mice. They are characterized by the expression of a single invariant TCRα chain (Vα14-Jα18 in mice, Vα24-Jα18 in human) in combination with certain TCRβ chains (using Vβ8.2, 7 or Vβ2 in mice, Vβ11 in human). While the iNKT cell population is in fact comprised of a multitude of clones that express different combinations of these TCRs, their uniform reactivity with CD1d tetramers loaded with the glycosphingolipid antigen α-galactosylceramide (α-Galcer) allows for the tracking of the iNKT population as a whole. This technical advantage has permitted the study of iNKT cell development in many genetically modified strains of mice and has led to the identification of several transcription factors and signaling pathways important for this process. Mature iNKT cells have a memory or activated phenotype (CD69+CD44high IL-2Rβhigh) and they also express several markers usually associated with the NK lineage from which their name was derived.

iNKT cells develop in the thymus where they segregate from conventional T cell development at the double-positive (DP) thymocyte stage, coincident with the acquisition of TCRαβ expression. Like conventional T cells, iNKT cell development requires recognition of their restriction element, CD1d, by the iNKT TCR. Both DP thymocytes and epithelial cells in the thymus express CD1d. However, iNKT cells are positively selected at the DP stage by CD1d-expressing DP cells themselves as opposed to epithelial cells that drive the selection of “conventional” T cells. It is thought that selection by DP cells imparts the unique developmental program of iNKT cells to the selected thymocytes due to homeotypic interactions across the DP-DP synapse that generate “second signals” mediated by the cooperative engagement of the homophilic receptors of at least two members of the signaling lymphocytic-activation molecule (SLAM) family (Slamf1 [SLAM] and Slamf6 [Ly108])5. Such engagements lead to the downstream recruitment of the adaptor SLAM-associated protein (SAP) and the Src kinase Fyn, both of which are essential for the expansion and differentiation of the iNKT cell lineage. Interestingly, CD4+ T cells positively selected by MHC class-II-expressing thymocytes also require these signals and share several features with iNKT cells6.

Once iNKT cells have been positively selected, they expand in the thymus and undergo orchestrated maturation that ultimately leads to their acquisition of the activated NK-like phenotype (see figure). This process relies on the proper expression of cytokine receptors, signal transduction molecules, transcription factors, and co-stimulatory molecules (see ref 7 for a recent review). However, none of the genes previously shown to participate in iNKT cell development are expressed exclusively in iNKT cells. By contrast, PLZF appears to be unique to iNKT cells. Using a combination of intracellular PLZF staining and measurements of PLZF mRNA expression levels by qPCR, Kovalovsky and colleagues show high expression of PLZF in iNKT cells while other immune cells, such as “conventional” T cells, NK cells, B cells, neutrophils, eosinophils and macrophages, do not express this transcription factor. PLZF expression is highest in HSAhigh CD44low thymic iNKT cells, a population thought to represent immature iNKT cells that have just undergone positive selection8. In agreement with a previous study of gene expression in developing iNKT cells (Affymetrix Probe set 1419874_x_at, ref 9), PLZF expression decreases as the cells mature, and remains expressed at high levels in mature iNKT cells relative to other lymphoid populations.

Figure 1
Schematic view of iNKT cell development

What are the signal(s) that induce PLZF expression in the early development of iNKT cells? We currently know that two signaling events are critical for the making of an iNKT cell. The first one involves recognition of CD1d + self-glycolipid(s) by the semi-invariant TCRs; the second one requires the engagement of SLAM family receptors. Because PLZF is expressed at wildtype levels in the very few iNKT cells that can be found in mice deficient for Fyn or SAP, two signaling molecules that convey the SLAM-mediated signals, Kovalovsky et al. concluded that SLAM-mediated signaling was likely not essential for PLZF expression. Although not definitive, these results suggest that perhaps a third, unknown, signal is necessary for the induction of PLZF expression. The surface molecules and cell types that might be involved in the PLZF-inducing pathway will likely be the focus of intense research in the near future.

PLZF is a transcription factor that has been implicated in the regulation of hip development, spermatogenesis, hematopoietic proliferation and differentiation, leukemogenesis and tumorigenesis. It is generally thought of as a transcriptional repressor due to its capacity to recruit mammalian Polycomb family members, which in turn recruit histone deacetylases. In the absence of PLZF very few iNKT cells develop, and the cells that are detected fail to fully upregulate several cell surface markers usually associated with iNKT cell maturation. These “immature” iNKT cells tend to accumulate in the lymph nodes and are deficient in several effector functions, such as the capacity to rapidly secrete IL-4 and IFNγ upon TCR triggering. These results suggest that PLZF controls, either directly or indirectly, several genes that are important for iNKT cell biology (i.e. cytokine secretion, cytotoxicity, migration). In future studies, it will be important to determine how PLZF acts within iNKT cells to control these various aspects of iNKT cells biology. Recent reports demonstrated that PLZF directly inhibits the expression of at least three different microRNAs (miRs) in melanoma and megakaryocytes10,11. In turn, these single-stranded 20 to 25 nucleotides non-coding RNAs regulate gene expression by targeting protein-coding mRNAs for translational repression and/or degradation. The presence of untranslated IL-4 mRNA in resting iNKT cells represents one of the hallmarks of the population (ref). The absence of this “pre-formed” IL-4 mRNA in resting PLZF-deficient iNKT cells could be consistent with such mechanism of regulation, either through the direct binding of miRs to the 3′ untranslated region of the IL-4 mRNA, or alternatively through the indirect regulation of genes involved in regulating message stability.

The localization and migratory behavior of the various cells that populate lymphoid tissues appears to be linked to their unique functions. Determining these parameters for iNKT cells should contribute greatly to our understanding of how these cells participate in the immune response. Just as the generation of the α-GalCer-loaded CD1d tetramer revolutionized and refined how researchers could study iNKT cells ex vivo 12,13, the identification of PLZF as an iNKT cell-specific gene might be a critical stepping stone in advancing our efforts to study iNKT cells in vivo. The identification of PLZF as a signature gene of iNKT cells opens the possibility of developing reagents to use PLZF as a molecular tracer of the population in vivo. It is currently unclear whether the new monoclonal antibody directed against PLZF that was developed in the Sant’Angelo laboratory will be useful for immunohistochemistry. However, one can readily envision using PLZF, as has been done with Foxp3 and Treg cells, in “knock-in” and/or BAC transgenic approaches to take advantage of the genomic regulatory regions of the Zbtb16 gene that codes for PLZF. The expression of genes of interest could be driven or abrogated in an iNKT-cell specific manner to track and/or modulate iNKT cell activities directly in vivo. One potential complication to the immediate usefulness of the identification of PLZF as a gene specifically expressed in iNKT cells comes from micro-array data derived from blood monocytes purified on the basis of FCS/SSC and CD11b expression14, which show high expression of PLZF in this monocyte population. This cell population was not examined in the study by Kovalovsky et al. and the results will have to be confirmed before we can formally assign PLZF as an iNKT cell-specific transcription factor.

Nevertheless, the findings now reported by Kovalovsky and colleagues represent an important milestone in our understanding of iNKT cell development and will likely open new areas of investigation of this unique lymphocyte population.

References

1. Melichar HJ, et al. Regulation of γδ versus αβ T lymphocyte differentiation by the transcription factor SOX13. Science. 2007;315:230–3. [PubMed]
2. He X, Kappes DJ. CD4/CD8 lineage commitment: light at the end of the tunnel? Curr Opin Immunol. 2006;18:135–42. [PubMed]
3. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol. 2007;8:457–62. [PubMed]
4. Kovalovsky D, et al. The BTB-zinc finger transcriptional regulator, PLZF, controls the development of iNKT cell effector functions. Nat Immunol. 2008 [PMC free article] [PubMed]
5. Griewank K, et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity. 2007;27:751–62. [PMC free article] [PubMed]
6. Li W, et al. The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. Immunity. 2007;27:763–74. [PMC free article] [PubMed]
7. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol. 2007;7:505–18. [PubMed]
8. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med. 2005;202:485–92. [PMC free article] [PubMed]
9. Matsuda JL, et al. T-bet concomitantly controls migration, survival and effector functions during the development of Vα 14i NKT cells. Blood. 2006;107:2797–2805. [PubMed]
10. Felicetti F, et al. The promyelocytic leukemia zinc finger-microRNA−221/−222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res. 2008;68:2745–54. [PubMed]
11. Labbaye C, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10:788–801. [PubMed]
12. Matsuda JL, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 2000;192:741–754. [PMC free article] [PubMed]
13. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med. 2000;191:1895–1903. [PMC free article] [PubMed]
14. Chambers SM, et al. Hematopoietic Fingerprints: An Expression Database of Stem Cells and Their Progeny. Cell Stem Cell. 2007;1:578–591. [PMC free article] [PubMed]